Loading
A phase 1 trial of SRN-101 run by Nicholas Butowski, not yet recruiting.
A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. is a phase 1 interventional study registered as NCT07826949 by Nicholas Butowski, with 6 participants planned, started 2026-11-15. Conditions recorded: Recurrent High-Grade Gliomas, Brain Neoplasm and Glioma. Interventions recorded: SRN-101, Blood Specimen Collection, Surgical Resection and Magnetic Resonance Imaging (MRI).
Shares SRN-101, Siren Biotechnology, Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Shares Brain and spinal cord tumours (all types) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/